+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Chemotherapy Induced Anemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767248
  • Report
  • April 2019
  • Region: Global
  • 43 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • 3SBio Inc
  • Affymax Inc
  • Amgen Inc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Novartis AG
  • MORE
The global clinical trial report- “2019 Chemotherapy Induced Anemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Chemotherapy Induced Anemia. It presents in-depth analysis of Chemotherapy Induced Anemia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Chemotherapy Induced Anemia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Chemotherapy Induced Anemia clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Chemotherapy Induced Anemia

The research work is prepared through extensive and continuous research on Chemotherapy Induced Anemia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Chemotherapy Induced Anemia patients are identified
  • The report includes panorama of Chemotherapy Induced Anemia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Chemotherapy Induced Anemia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 3SBio Inc
  • Affymax Inc
  • Amgen Inc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Novartis AG
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Chemotherapy Induced Anemia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Chemotherapy Induced Anemia Clinical Trials by Region
2.2.2 Average Enrollment of Chemotherapy Induced Anemia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Chemotherapy Induced Anemia Treatment, 2019

3. Region wise Chemotherapy Induced Anemia Clinical Trials
3.1 Asia Pacific Chemotherapy Induced Anemia Clinical Trials by Country
3.2 Europe Chemotherapy Induced Anemia Clinical Trials by Country
3.3 North America Chemotherapy Induced Anemia Clinical Trials by Country
3.4 Middle East and Africa Chemotherapy Induced Anemia Clinical Trials by Country
3.5 South and Central America Chemotherapy Induced Anemia Clinical Trials by Country

4. Chemotherapy Induced Anemia Clinical Trial Trends
4.1 Start Year wise Chemotherapy Induced Anemia Clinical Trials
4.2 Phase wise Chemotherapy Induced Anemia Clinical Trials
4.3 Trial Status wise Chemotherapy Induced Anemia Clinical Trials
4.4 Trial Type wise Chemotherapy Induced Anemia Clinical Trials

5. Chemotherapy Induced Anemia Average Enrollment Trends
5.1 Average Enrollment in Chemotherapy Induced Anemia Trials by Year
5.2 Average Enrollment in Chemotherapy Induced Anemia Trials by Phase
5.3 Average Enrollment in Chemotherapy Induced Anemia Trials by Status
5.4 Average Enrollment in Chemotherapy Induced Anemia Trials by Type of Trial

6. Companies Participating in Chemotherapy Induced Anemia Clinical Trials
6.1 Chemotherapy Induced Anemia Trials by Sponsor Type
6.2 Chemotherapy Induced Anemia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Chemotherapy Induced Anemia Trials- Phase 1
7.2 Chemotherapy Induced Anemia Trials- Phase 2
7.3 Chemotherapy Induced Anemia Trials- Phase 3
7.4 Chemotherapy Induced Anemia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Chemotherapy Induced Anemia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Chemotherapy Induced Anemia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Chemotherapy Induced Anemia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Chemotherapy Induced Anemia Clinical Trials and Enrolment
Figure 7: North America - Country wise Chemotherapy Induced Anemia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Chemotherapy Induced Anemia Clinical Trials and Enrolment
Figure 9: Chemotherapy Induced Anemia Clinical Trials by Phase
Figure 10: Chemotherapy Induced Anemia Clinical Trials by Trial Status
Figure 11: Chemotherapy Induced Anemia Clinical Trials by Type
Figure 12: Chemotherapy Induced Anemia Clinical Trials by Sponsor Type
Figure 13: Chemotherapy Induced Anemia Clinical Trials by Leading Sponsors
Figure 14: Chemotherapy Induced Anemia Average Enrollment by Phase
Figure 15: Chemotherapy Induced Anemia Average Enrollment by Trial Status
Figure 16: Chemotherapy Induced Anemia Average Enrollment by Type
Figure 17: Chemotherapy Induced Anemia- Average Enrolment by Type of Sponsors
Figure 18: Chemotherapy Induced Anemia- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Chemotherapy Induced Anemia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Chemotherapy Induced Anemia Clinical Trials and Enrolment
Table 5: Europe - Country wise Chemotherapy Induced Anemia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Chemotherapy Induced Anemia Clinical Trials and Enrolment
Table 7: North America - Country wise Chemotherapy Induced Anemia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Chemotherapy Induced Anemia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Chemotherapy Induced Anemia Average Enrollment by Phase
Table 15: Chemotherapy Induced Anemia Average Enrollment by Trial Status
Table 16: Chemotherapy Induced Anemia Average Enrollment by Type
Table 17: Chemotherapy Induced Anemia- Average Enrolment by Type of Sponsors
Table 18: Chemotherapy Induced Anemia- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3
  • 3SBio Inc
  • Affymax Inc
  • Amgen Inc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Novartis AG
  • Ortho Biotech Products LP
  • Pfizer Inc
  • Pharmacosmos AS
  • SBI Holdings Inc.
Note: Product cover images may vary from those shown
Adroll
adroll